Skip to main content
. 2022 Oct;10(20):1123. doi: 10.21037/atm-22-4304

Table 3. Clinical characteristics of SMPP in children and adults.

Characteristics Children (n=281) Adults (n=20) P value
Clinical presentation (n, %)
   Common symptoms 281/281 (100.00) 20/20 (100.00) 1.0000
   Extrapulmonary symptoms 116/281 (41.28) 3/20 (15.00) 0.0306
Laboratory detection (range)
   White blood cells (×109/L) 6.3 (2.8–16.4) 7.9 (3.9–20.1) 0.1026
   Neutrophil rate (%) 62.8 (22.4–81.7) 65.4 (30.2–87.2) 0.3801
   Lymphocyte rate (%) 28.8 (9.5–65.0) 31.0 (8.1–60.4) 0.4661
   C-reactive protein (mg/L) 125.4 (27.1–237.3) 66.3 (10.2–125.6) <0.0001
   LDH (U/L) 447 [150–1,129] 309 [170–620] 0.0032
Imaging manifestations (n, %)
   Unilobar infiltration 83/281 (29.54) 12/20 (60.00) 0.0105
   Multilobar infiltrates 198/281 (70.46) 8/20 (40.00) 0.0105
   Pleural effusion 115/281 (40.63) 6/20 (30.00) 0.4797

Common symptoms: cough, sputum, headache, sore throat, fever, malaise, chest pain, tachypnea; extrapulmonary symptoms: skin rash, meningitis, myocarditis, hemolytic anemia, myalgia, digestive symptoms, hemolytic anemia and nephritis. SMPP, severe Mycoplasma pneumoniae pneumonia; LDH, lactate dehydrogenase.